Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Bacterial Infections

• Parenteral Versus Combined Parenteral With Vancomycin-soaked Graft in ACL Reconstruction
• PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment
• Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants
• P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants
• Monolaurin Ointment Versus Mupirocin Ointment
• Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
• TDM-optimized Teicoplanin Dosing Versus Standard of Care
• CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
• Evaluation of the Impact of an Amoxicillin and Amoxicillin/Clavulanic Acid Resistant Probiotic on Key Clinical Outcomes in Children Treated With Amoxicillin or Amoxicillin/Clavulanic Acid
• Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial
• To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100.
• Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100
• Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)
• A Study to Evaluate Efficacy, Safety, and Pharmacokinetics of XEMBIFY® Plus Standard Medical Treatment (SMT) Compared to Placebo Plus SMT to Prevent Infections in Participants With Hypogammaglobulinemia and Recurrent or Severe Infections Associated
• Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
• PMT for MDRO Decolonization
• A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections
• Safety of Intravenous Apramycin in Adults
• Effect of PreforPro® on Urinary and Vaginal Health
• Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women
• Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLED
• A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection
• PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections
• A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS
• Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
• S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections
• Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects
• Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections
• A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers
• Addition of Probenecid to Penicillin-V Therapy
• Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects
• Complications After Lower Third Molar Surgery
• Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine
• Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
• Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection
• Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition
• Antibiotics Continuous Infusion at Home
• SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers
• Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects
• To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females.
• Pharmacokinetics of XNW4107 in Subjects With Various Degrees of Renal Function
• Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
• Efficacy and Safety of Colistin Based Antibiotic Therapy
• Use of Preoperative and Postoperative Antimicrobial Treatment
• Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults
• Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.
• Drug-drug Interaction Study of Gepotidacin
• Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue
• Study to Evaluate Safety, Tolerability, and Pharmacokinetics of XNW4107 Alone or in Combination With Imipenem/Cilastatin
• Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection
• P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV
• Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Patients
• Economic Evaluation of Vancomycin Therapeutic Drug Monitoring Methods
• [18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
• Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients
• Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
• Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.
• Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects
• Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX)
• Treatment of BV With First Deqularum and Then Direkt After Clindamycin
• A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)
• Dalbavancin Outpatient Pilot
• A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam
• Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)
• TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection
• Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects
• A Single Ascending Dose Study of AV-006 in Healthy Subjects
• Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial
• Intravenous Fosfomycin Pharmacokinetics Study
• Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)
• PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients
• Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301
• Topical Silver Nanoparticles for Microbial Activity
• Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
• A Safety and PK Study of IV Eravacycline
• PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
• Serum Ceftazidime Concentrations in Hemodialysis Patients
• Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
• A Single Ascending Dose Study of BTZ043
• Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria
• Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)
• Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function
• Plasma Protein Binding and PK/PD of Total and Unbound Temocillin Non-ICU Patients
• A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study
• Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units
• Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients
• 11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
• Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions
• Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections
• Minocycline Pharmacokinetics (ACUMIN)
• VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers
• A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions
• A Phase 1 Safety and PK Study of IV TP-271
• Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
• A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)
• A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants
• Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects
• Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome
• Chlorhexidine Gluconate Versus Povidone-Iodine as Vaginal Preparation Antiseptics Prior to Cesarean Delivery
• Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection
• A Phase 1 TP-271 Oral PK Single Ascending Dose Study
• Evaluation of ATx201 as a Topical Antibiotic Agent
• VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers
• Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT)
• Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI
• To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.
• Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
• Evaluating Newly Approved Drugs for Multidrug-resistant TB
• Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer
• A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830
• A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
• Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
• Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
• Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
• Staph Household Intervention for Eradication (SHINE)
• High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
• Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics
• PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children
• A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis
• Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
• Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites
• Study of Debio 1450 for Bacterial Skin Infections
• Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)
• Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
• Temocillin Pharmacokinetic in Hemodialysis
• MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection
• Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
• Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
• A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers
• A Single Dose Study of Debio 1450 in Healthy Subjects
• Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.
• A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595
• Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
• Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients
• RCT: Triple vs Sequential vs Concomitant Therapy H Pylori
• Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants
• Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
• Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
• Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects
• Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
• The INFECIR-2 Albumin Prevention Study
• Telavancin Pediatric PK Study (Ages >3 Months to 17 Years)
• Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure
• Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents
• A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
• TD-1607 MAD Study in Healthy Subjects
• A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.
• To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944
• Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects
• A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects
• Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
• Retapamulin Microdialysis Feasibility Study
• Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
• Prevention of Bacterial Infections in Newborn
• Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination
• Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects
• Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients
• Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
• Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem
• Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
• To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)
• Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication
• A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose
• A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects
• Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients
• WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics
• Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination
• Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy
• Post Marketing Surveillance Study on Linezolid
• A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
• Helicobacter Eradication Aspirin Trial
• ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)
• Amoxicillin Bioequivalence Study Brazil - Fast
• TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
• A Study of Doripenem in Infants Less Than 12 Weeks of Age
• Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
• A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
• Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg
• A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects
• Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2
• Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction
• Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study
• GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection
• TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
• Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients
• United States Pharmacovigilence Retapamulin-Prescribing
• In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance
• Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
• Cerebral Antibiotics Distribution After Acute Brain Injury
• Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule
• A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and th
• Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
• Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections
• Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
• Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)
• Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)
• A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
• Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM)
• Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate
• Relative Bioavailability Study in Healthy Subjects
• A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects
• Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA
• Single Dose Escalation First Time in Human PK Study
• A Study To Assess The Effect Of Linezolid On QTc Interval
• An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates
• Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients
• Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)
• Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416
• Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections
• BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
• Ciprofloxacin on Burned Patients
• Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
• Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery
• Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers
• Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers
• A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in Adult
• Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
• Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus
• A Study of Ceftobiprole in Patients With Fever and Neutropenia.
• To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects
• Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride
• A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
• A Study in Sepsis Patients With Renal Failure
• Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients
• Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections
• Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis
• Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
• Study Evaluation Tazocin Intervention
• Tazocin Intervention Study
• Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients
• A Three-Part Study Of GSK580416 In Healthy Subjects
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
• Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
• Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
• Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
• Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)
• Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers
• Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers
• Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers
• Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers
• Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers
• A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
• Therapeutic Zinc in Infant Bacterial Illness
• Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
• Steroids for Corneal Ulcers Trial
• Evaluation of Atuna Racemosa Toxicity
• Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
• A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections
• Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)
• Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
• Doripenem in the Treatment of Complicated Intra-Abdominal Infections
• Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.
• Doripenem in the Treatment of Complicated Intra-Abdominal Infections
• A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection
• Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.
• Etiology, Prevention and Treatment of Neonatal Infections in the Community
• Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
• Reducing Vaginal Infections in Women
• Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
• Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit
• Time To Efficacy and Onset Of Action Of Linezolid
• Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
• Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
• Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
• Unfractioned Heparin for Treatment of Sepsis
• Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects
• Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms
• Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)
• Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia
• Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
• Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection
• Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria
• New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)
• New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
• Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
• A Study of Azithromycin in HIV-Infected Patients
• Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
• Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites
• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children